CRSwNP significantly related to Th1/Th2/Th17 cytokines compared to controls. In addition, the signature inflammatory markers, which were at the highest level among all the groups, of non-eosinophilic CRSwNP is interleukin (IL)-17A, IL-1β (markers for Th17), matrix metallopeptidase (MMP)-9 (a marker for neutrophil), whereas IL-5, C-C motif chemokine ligand (CCL)-11, monocyte chemoattractant protein (MCP)-4 (markers for Th2), and vascular cell adhesion molecule (VCAM)-1 were signature inflammatory markers in eosinophilic CRSwNP. Interestingly, although 2 groups showed different signature inflammatory profiles, non-eosinophilic and eosinophilic CRSwNP patients showed common changes of several immunologic profiles on the paired comparison between UP and NP. It indicates that the increased Th2 immune response from UP to NP tissues on both CRSwNP endotype. Additionally, on performed the principal component analysis (PCA) in different CRS groups, the PCA2 component, which indicated a relative Th2 profile, can help to discriminate among the different subgroups of CRS (CRSsNP-UP vs. CRSwNP-UP vs. non-eosinophilic CRSwNP-NP vs. eosinophilic CRSwNP-NP). These findings mean that there is a continuum among subtypes of CRS based on Th2 inflammatory mediators.
As you known that, in the human study, it is very difficult to prove the mechanism for the evolution of nasal polypogenesis. This is because the CRS patient must be monitored for several years and the immunologic changes must be verified by continuous testing until the nasal polyp develops. This study used UP tissues where NP occurs commonly, as internal controls, then, compared the changes between UP and NP, within the same patient. Thus, although this is a cross-sectional study, these comparisons may tell us what the key protein is while nasal mucosa changes to NP. Moreover, our unpublished data show that the symptom duration in patients with non-eosinophilic CRSwNP has a positive correlation with IL-5 (r = 0.5658, P = 0.0223), CCL-11 (r = 0.5694, P = 0.0213), and IL-10 (r = 5201, P = 0.0389). These results suggest immunologic endotype may change according to the disease duration which can give a clue about CRS evolution.
In summary, the increase of Th2 cytokines in NP compared to UP was shown irrespective of subtypes of CRSwNP, whereas signature cytokines were distinct in each nasal tissue in subtypes of CRS. Carefully, we suggest that non-eosinophilic CRSwNP showed increased Th2 immune response according to the prolonged disease duration, implying the likelihood of non-eosinophilic CRSwNP being changed into eosinophilic.
